Physician
Pathology
Dr. Dean A. Troyer, MD
|
|
Give Review
Dean Troyer is an expert in the field of Pathology. He attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received awards:"National Research Service Award" and "Graduated with Departmental Honors, Chemistry". Doctor Dean A. Troyer, MD is also a published doctor. He has 101 publication published. The most recent publication is: Symptomatic splenic hamartoma: case report and literature review. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- DNA methylation profiles in African American prostate cancer patients in relation to disease progression.
- Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
- Complex-I alteration and enhanced mitochondrial fusion are associated with prostate cancer progression.
- Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
- Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies.
- MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.
- miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.
- A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
- Molecular Preservation by Extraction and Fixation, mPREF: A Method for Small Molecule Biomarker Analysis and Histology on Exactly the Same Tissue.
- MALDI tissue imaging: from biomarker discovery to clinical applications.
- Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies.
- Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.
- Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.
- The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
- Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases.
- Association of polymorphisms in TGFB1 and prostate cancer prognosis.
- Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
- Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
- A preliminary study of the baboon prostate pathophysiology.
- Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation.
- Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model media...
- External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
- Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
- A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
- The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
- Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.
- Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology.
- Multiple primary malignant neoplasms: case report and a comprehensive review of the literature.
- p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumors.
- Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
- Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
- Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
- Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen.
- Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.
- Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
- Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
- Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer.
- Obesity, adipokines, and prostate cancer in a prospective population-based study.
- Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
- Characterization of PacMetUT1, a recently isolated human prostate cancer cell line.
- Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from un...
- Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinic...
- Biomarkers for prostate cancer detection.
- Blockade of transforming growth factor-beta (TGF?) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line.
- Prognostic features in men who died of prostate cancer.
- Relationship of body mass index and prostate specific antigen in a population-based study.
- Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors.
- A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control ...
- Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.
- Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.
- Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice.
- The association of body mass index and prostate-specific antigen in a population-based study.
- Prostate cancer prevention: what do we know now and when will we know more?
- Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
- Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.
- 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
- Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.
- Genetic pattern of prostate cancer progression.
- Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.
- Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
- The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary...
- Effects of energy intake on type 1 plasminogen activator inhibitor levels in glomeruli of lupus-prone B/W mice.
- Epididymal rhabdomyoma.
- Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids.
- Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.
- The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study.
- Molecular pathology of prostate cancer.
- Tyrosine phosphorylation of focal adhesion kinase (p125FAK): regulation by cAMP and thrombin in mesangial cells.
- The effects of dietary lipids on gene expression and apoptosis.
- SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
- Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.
- Vasopressin and phorbol ester-stimulated phosphatidylcholine metabolism in mesangial cells.
- High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures.
- Phorbol ester inhibits arginine vasopressin activation of phospholipase C and promotes contraction of, and prostaglandin production by, cultured mesangial cells.
- Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren's syndrome.
- Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression.
- A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA.
- Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
- Stimulation of the thrombin receptor of human glomerular mesangial cells by Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe peptide.
- Calorie restriction decreases platelet-derived growth factor (PDGF)-A and thrombin receptor mRNA expression in autoimmune murine lupus nephritis.
- Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(1) mice fed a diet enriched with (n-3) fatty acids.
- Demonstration of the extrinsic coagulation pathway in teleostei: identification of zebrafish coagulation factor VII.
- Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).
- Regulation of mesangial cell function by thrombin.
- Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy.
- Neutrophil collagenase (MMP-8) is expressed during early development in neural crest cells as well as in adult melanoma cells.
- Symptomatic splenic hamartoma: case report and literature review.
- Disruption of functions of wild-type p53 by hetero-oligomerization.
- Cloning and characterization of the gene for a new epithelial beta-defensin. Genomic structure, chromosomal localization, and evidence for its constitutive expression.
- Identification and characterization of zebrafish thrombocytes.
- Genetic fieldwork for hereditary prostate cancer studies.
- Inositol phospholipid metabolism in the kidney.
- Lipid alterations in LLC-PK1 cells exposed to mercuric chloride.
- Pathology and pathogenesis of nephrotoxic membrane damage.
- Isolation and study of glomerular cells.
- Elevation of cAMP in cultured mesangial cells diminishes vasopressin-stimulated increases of phosphate uptake and 32P-specific activity in ATP but has no effect on pho...
- Effects of vasopressin on phosphoinositides and prostaglandin production in cultured mesangial cells.
- Biorepository standards and protocols for collecting, processing, and storing human tissues.
- Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy.
- Robotic-assisted laparoscopic partial cystectomy for symptomatic urachal hamartoma.
Schools
Indiana University School of Medicine
Med Center HospU Tex Health Science Center
University Tex Hsc
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- National Research Service Award
- Graduated with Departmental Honors, Chemistry
Education
-
University of Texas Health Science Center -
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1598772832 | |
| NPPES Provider LastName | TROYER | |
| NPPES Provider FirstName | DEAN | |
| NPPES Provider ZIPCode | 235071904 | |
| NPPES Provider State | VA | |
| Specialty Description | Pathology | |
| Total Claim Count | 15.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598772832 |
| Last Name Of The Provider | TROYER |
| First Name Of The Provider | DEAN |
| View All |
Similar Doctors
|
|
Dr. Maria A. Aguiar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Blumberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry H. Hellman Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jimmy W. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Savvas E. Mendrinos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele R. Roullet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Sparrer, MD
This Doctor is OpenDoctor Recommended.
|